Skip to main content
Clinical Trials/NL-OMON25783
NL-OMON25783
Completed
未知

Effectiveness and cost-effectiveness of monitoring spondyloarthritis with the integrated eHealth system SpA-Net: a randomized controlled trial

ReumaNederland0 sites200 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ReumaNederland
Enrollment
200
Status
Completed
Last Updated
last year

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
ReumaNederland

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible for participation in this study, subjects must meet all of the following criteria: • Adult patient (18\+ years) • Diagnosis of SpA according to treating physician • At least 2 years of disease duration, to be familiar with signs, symptoms, and medication • Stable disease, defined as being in a patient acceptable symptom state according to patient AND treating physician (36\) AND no treatment change expected in the next few months • Access to a computer, tablet and/or smartphone for the entire duration of the study

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study: • Insufficient mastery of Dutch language • Incompetent to act for oneself • Limited life expectancy • Ongoing (or planned) pregnancy during the study period • Patients participating in other research project(s)

Outcomes

Primary Outcomes

Not specified

Similar Trials